Abstract
Subclinical synovitis is highly prevalent in patients with JIA in clinical remission (CR) with a short duration. The objective was to evaluate its prevalence by ultrasound (US) in patients with JIA in long CR during a one-year follow-up. In this prospective and longitudinal study, we included 76 patients with JIA according to ILAR with CR by the Wallace modified criteria and JADAS27 and compared them with 22 patients with active disease. Clinical and demographic characteristics were recorded. US evaluation was by 10-joint count. Differences in US evaluations were analyzed by the Mann–Whitney U test. There were no differences among the two group with regard to disease duration at enrollment, and age (p = 0.540 and p = 0.080, respectively), but JADAS 27, CHAQ, and acute phase reactants were significantly higher (p < 0.001) in the clinically active group. The prevalence of subclinical synovitis at baseline and the end of the study in the CR group was 18.4% and 11.8%, respectively, while it was 100% and 40.9% in the active disease group. Subclinical synovitis at baseline was significantly more prevalent in the clinically active group (elbow, p = 0.01; wrist, p = 0.001; MCP 2, p = 0.001; knee, p = 0.001 and ankle p = 0.001; and PD only in the ankle, p = 0.002). The concordance of inter-reader reliability in all evaluated joints was excellent (p = 0.001). Although the prevalence of subclinical synovitis is low in patients with JIA with long-term clinical remission on medication, a percentage of patients continue to have subclinical involvement that could predict the risk of relapse and structural damage.
Key Points • Subclinical synovitis is less prevalent in JIA in long-term clinical remission compared to patients in short-term remission. • The persistence of imaging signs of inflammation in a significant percentage of patients may indicate the need for ongoing medication. |
Data availability
The data of this study are available.
References
Consolaro A, Giancane G, Schiappapietra B, Davi S, Calandra S, Lanni S et al (2016) Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol 14:23
Magnani A, Pistorio A, Magni-Manzoni S, Falcone A, Lombardini G, Bandeira M et al (2009) Achievement of a state of inactive disease at least once in the first 5 years predicts the better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol 36:628–634
Martini A, Lovell DJ (2010) Juvenile idiopathic arthritis: state of the art and future perspectives. Ann Rheum Dis 69:1260–1263
Consolaro A, Negro G, Lanni S, Solari N, Martini A, Ravelli A (2012) Toward a treat-to-target approach in the management of juvenile idiopathic arthritis. Clin Exp Rheumatol 30(4):S157
Shoop-Worrall SJW, Verstappen SMM, Baildam E, Chieng A, Davidson J, Foster H et al (2017) How common is a clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis. The importance of definition. Ann Rheum Dis 76:1381–1388
Shoop-Worrall SJW, Verstappen SMM, McDonagh JE, Baildam E, Chieng A, Davidson J et al (2018) Long-term outcomes following achievement of clinically inactive disease in juvenile idiopathic arthritis. The Importance of Definition. Arthritis Rheumatol 70:1519–1529
Brunner E, Ting T, Vega-Fernandez P (2020) Musculoskeletal ultrasound in children: current state and future directions. Eur J Rheumatol 7(Suppl 1):S28–S37
Zhao Y, Rascoff NE, Iyer RS, Thapa M, Reichley L, Oron AP et al (2018) Flares of disease in children with clinically inactive juvenile idiopathic arthritis were not correlated with ultrasound findings. J Rheumatol 45:851–857
Collado P, Gamir ML, López-Robledillo JC, Merino R, Modesto C, Monteagudo I (2014) Detection of synovitis by ultrasonography in clinically inactive juvenile idiopathic arthritis on and off medication. Clin Exp Rheum 32:597–603
De Luzia O, Ravagnani V, Pregnolato F, Hila A, Pontikaki I, Gattinara M et al (2018) Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA). Ann Rheum Dis 77:1426–1431
Nieto-González JC, Rodríguez A, Gamir-Gamir ML, Boteanu A, López-Robledillo JC, Garulo DC et al (2019) Can ultrasound-detected subclinical synovitis be an indicator of flare recurrence in juvenile idiopathic arthritis remission patients on tapered TNFi? Clin Exp Rheum 37:705–712
Brown A, Hirsch R, Laor T, Hannon MJ, Levesque MC, Starz T et al (2012) Do patients with juvenile idiopathic arthritis in clinical remission have evidence of persistent inflammation on 3T magnetic resonance imaging? Arthritis Care Res (Hoboken) 64:1846–1854
Miotto e Silva VB, Vilela Mitraud SA, Vilar Furtado RN, Natour J, Arnaldo Len C, de Sande MT et al (2017) Patients with juvenile idiopathic arthritis in clinical remission with positive power Doppler signal in joint ultrasonography have an increased rate of clinical flare : a prospective study. Pediatr Rheumatol 15:80
Bazso A, Consolaro A, Ruperto N, Pistorio A, Viola S, Magni-Manzoni S et al (2009) Development and testing of reduced joint counts in juvenile idiopathic arthritis. J Rheumatol 36:183–190
Collado P, Naredo E, Calvo C, Gamir LM, Calvo I, García ML et al (2013) Reduced joint assessment vs comprehensive assessment for ultrasound detection of synovitis in juvenile idiopathic arthritis. Rheumatology 52:1477–1484
Roth J, Ravagnani V, Backhaus M, Balint P, Bruns A, Bruyn GA et al (2017) Preliminary definitions for the sonographic features of synovitis in children. Arthritis Care Res 69:1217–1229
Collado P (2014) Ultrasound imaging in juvenile idiopathic arthritis for the rheumatologist. Clin Exp Rheumatol 32(1 Suppl 80):S34–S41
Rossi-Semerano L, Breton S, Semerano L, Boubaya M, Ohanyan H, Bossert M, Boiu S et al (2021) Application of the OMERACT synovitis ultrasound scoring system in juvenile idiopathic arthritis: a multicenter reliability exercise. Rheumatology 60:3579–3587
Guzmán J, Oen K, Huber AM, Boire G, Duffy KW, Berard R et al (2014) The risk and nature of flares in juvenile idiopathic arthritis: results from the reACCh-Out cohort. Pediatr Rheumatol 12(Suppl 1):O9
Baszis K, Garbutt J, Toib D, Mao J, King A, White A et al (2011) Clinical outcomes after withdrawal of anti-tumour necrosis factor-alpha therapy in patients with juvenile idiopathic arthritis: a twelve-year experience. Arthritis Rheum 63:3163–3168
Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH (2005) Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 52:3554–3562
Selvaag AM, Aulie H, Lilleby V, Flato B (2016) Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis. Ann Rheum Dis 75:190–195
Packham JC, Hall MA (2002) Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology 41:1428–1435
Knowlton N, Jiang K, Frank MB, Aggarwal A, Wallace A, McKee R et al (2009) The meaning of clinical remission in polyarticular juvenile idiopathic arthritis gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states. Arthritis Rheum 60:892–900
Ventura-Ríos L, Faugier E, Barzola L, De la Cruz-Becerra LB, Sánchez-Bringas G, Rodríguez García A et al (2018) Reliability of ultrasonography to detect inflammatory lesions and structural damage in juvenile idiopathic arthritis. Pediatric Rheumatol 16:58
Acknowledgements
Our acknowledgment to Dr. Johannes Roth for reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Loredo, C., Yañez, P., Hernández-Díaz, C. et al. Low prevalence of subclinical synovitis in patients with juvenile idiopathic arthritis (JIA) in long-term clinical remission on medication. Clin Rheumatol 43, 393–398 (2024). https://doi.org/10.1007/s10067-023-06729-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-023-06729-y